1. Home
  2. GLMD vs VERB Comparison

GLMD vs VERB Comparison

Compare GLMD & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • VERB
  • Stock Information
  • Founded
  • GLMD 2000
  • VERB 2014
  • Country
  • GLMD Israel
  • VERB United States
  • Employees
  • GLMD N/A
  • VERB N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • VERB Other Consumer Services
  • Sector
  • GLMD Health Care
  • VERB Consumer Discretionary
  • Exchange
  • GLMD Nasdaq
  • VERB Nasdaq
  • Market Cap
  • GLMD 4.5M
  • VERB 4.7M
  • IPO Year
  • GLMD 2014
  • VERB N/A
  • Fundamental
  • Price
  • GLMD $1.46
  • VERB $4.31
  • Analyst Decision
  • GLMD
  • VERB Strong Buy
  • Analyst Count
  • GLMD 0
  • VERB 1
  • Target Price
  • GLMD N/A
  • VERB $100.00
  • AVG Volume (30 Days)
  • GLMD 2.6M
  • VERB 33.5K
  • Earning Date
  • GLMD 05-29-2025
  • VERB 05-09-2025
  • Dividend Yield
  • GLMD N/A
  • VERB N/A
  • EPS Growth
  • GLMD N/A
  • VERB N/A
  • EPS
  • GLMD N/A
  • VERB N/A
  • Revenue
  • GLMD N/A
  • VERB $895,000.00
  • Revenue This Year
  • GLMD N/A
  • VERB $36.76
  • Revenue Next Year
  • GLMD N/A
  • VERB N/A
  • P/E Ratio
  • GLMD N/A
  • VERB N/A
  • Revenue Growth
  • GLMD N/A
  • VERB 1320.63
  • 52 Week Low
  • GLMD $1.33
  • VERB $4.29
  • 52 Week High
  • GLMD $23.80
  • VERB $53.60
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 33.38
  • VERB 36.22
  • Support Level
  • GLMD $1.33
  • VERB $4.51
  • Resistance Level
  • GLMD $1.55
  • VERB $4.99
  • Average True Range (ATR)
  • GLMD 0.33
  • VERB 0.54
  • MACD
  • GLMD -0.04
  • VERB -0.07
  • Stochastic Oscillator
  • GLMD 5.90
  • VERB 0.95

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

Share on Social Networks: